Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Priority to UY27931ApriorityCriticalpatent/UY27931A1/en
Publication of UY27931A1publicationCriticalpatent/UY27931A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Derivados de 2,3-dihidro-isoindol-1.ona, procesos para su producción, su uso como composiciones farmacéuticas y medicamentos que las comprenden, para la prevención y tratamiento de enfermedades que son mediadas por inhibidores de la monoaminoxidasa BDerivatives of 2,3-dihydro-isoindol-1.one, processes for its production, its use as pharmaceutical compositions and medicines that comprise them, for the prevention and treatment of diseases that are mediated by monoamine oxidase B inhibitors
NEW DERIVATIVES OF 1,4-BENZOTIEPINA-1,1-DIOXIDE REPLACED WITH CYCLHEXYL RADICALS, METHOD FOR THEIR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THESE COMPOUNDS AND THEIR USE.
DERIVATIVES OF FITTED HETERO-PENTACICLO-FENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF A CONDITION MEDIATED BY P38